Kabra Drugs has informed that a meeting of the Board of Directors of the Company will be held on October 15, 2015, to issue Duplicate Share Certificates to the shareholders, to accept resignation of Ramesh Rai from the Board, to constitute Audit Committee by reconstituting the existing Audit Committee, to constitute Nomination and Remuneration Committee by reconstituting the existing Nomination and Remuneration Committee, and to constitute independent Directors Committee by reconstituting the existing Independent Directors Committee.
The above information is a part of company’s filings submitted to BSE.